Ameriprise
OCGN icon

Ameriprise’s Ocugen OCGN Stock Holding History

Ameriprise’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,850
Closed -$28.7K – 4215
2026
Q1 		$28.7K Buy
15,850
+275
+2% +$476 ﹤0.01% 4023
2025
Q4 		$21K Buy
+15,575
New +$22.2K ﹤0.01% 4061
2025
Q2 		– Sell
-38,102
Closed -$26.9K – 4086
2025
Q1 		$26.9K Buy
38,102
+557
+1% +$385 ﹤0.01% 3967
2024
Q4 		$30.2K Buy
+37,545
New +$34.4K ﹤0.01% 4033
2023
Q1 		– Sell
-35,758
Closed -$46K – 4012
2022
Q4 		$46K Sell
35,758
-90
-0.3% -$140 ﹤0.01% 3866
2022
Q3 		$63K Sell
35,848
-8,200
-19% -$20.4K ﹤0.01% 3876
2022
Q2 		$100K Sell
44,048
-5,615
-11% -$13.4K ﹤0.01% 3781
2022
Q1 		$164K Sell
49,663
-1,710
-3% -$6.01K ﹤0.01% 3787
2021
Q4 		$233K Sell
51,373
-35,485
-41% -$268K ﹤0.01% 3750
2021
Q3 		$624K Buy
86,858
+5,300
+6% +$38.9K ﹤0.01% 3332
2021
Q2 		$655K Buy
81,558
+56,800
+229% +$479K ﹤0.01% 3366
2021
Q1 		$168K Buy
+24,758
New +$165K ﹤0.01% 3723

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ameriprise's OCGN Position: Q2 2026 in Review

Ameriprise sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 15,850 shares — an estimated $28.7K sold.

Ameriprise first reported a position in OCGN in Q1 2021 and held it in 12 quarters. The position peaked at $655K in Q2 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Ameriprise reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 15,850 Ocugen shares in Q2 2026, an estimated $28.7K.
  • Ameriprise first reported a position in Ocugen in Q1 2021 and held it in 12 quarters.
  • Ameriprise's Ocugen position peaked at $655K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.